According to RaiaDrogasil's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 48.8143. At the end of 2021 the company had a P/E ratio of 53.3.
Year | P/E ratio | Change |
---|---|---|
2021 | 53.3 | -37.48% |
2020 | 85.2 | 79.01% |
2019 | 47.6 | 28.11% |
2018 | 37.2 | -37.22% |
2017 | 59.2 | 32.41% |
2016 | 44.7 | 30.15% |
2015 | 34.4 | -8.88% |
2014 | 37.7 | -22.02% |
2013 | 48.4 | -34.7% |
2012 | 74.0 | 23.31% |
2011 | 60.0 | 120.33% |
2010 | 27.3 | 25.53% |
2009 | 21.7 | -15.98% |
2008 | 25.8 | -32.42% |
2007 | 38.2 | 237.61% |
2006 | 11.3 | 175.14% |
2005 | 4.12 | -30.44% |
2004 | 5.92 | 9.47% |
2003 | 5.41 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.